The business of pharmacogenomics

Nat Biotechnol. 1998 Feb;16(2):209-10. doi: 10.1038/nbt0298-209.
No abstract available

MeSH terms

  • Drug Design*
  • Drug Industry
  • Humans
  • Pharmacogenetics*